PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20181615-2	2010	A current clinical target for B-cell lymphoma is CD22, a B-cell-specific member of the sialic acid binding Ig-like lectin (siglec) family that recognizes alpha2-6-linked sialylated glycans as ligands.	Polysaccharides	181-188	CD22 molecule	Homo sapiens	49-53	
20181615-3	2010	Here, we describe a novel approach for targeting B lymphoma cells with doxorubicin-loaded liposomal nanoparticles displaying high-affinity glycan ligands of CD22.	Polysaccharides	139-145	CD22 molecule	Homo sapiens	157-161